AJP - Regu Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 292: R382-R387, 2007. First published August 10, 2006; doi:10.1152/ajpregu.00496.2006
0363-6119/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/1/R382    most recent
00496.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Samson, W. K.
Right arrow Articles by White, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Samson, W. K.
Right arrow Articles by White, M. M.

NEUROHUMORAL CONTROL OF CARDIOVASCULAR FUNCTION

Hypocretin/orexin type 1 receptor in brain: role in cardiovascular control and the neuroendocrine response to immobilization stress

Willis K. Samson,1 Sara L. Bagley,1 Alastair V. Ferguson,2 and Meghan M. White1

1Department of Pharmacological and Physiological Science, Saint Louis University School of Medicine, St. Louis, Missouri; and 2Department of Physiology, Queen's University, Kingston, Ontario, Canada

Submitted 13 July 2006 ; accepted in final form 9 August 2006

Hypocretin/orexin acts pharmacologically in the hypothalamus to stimulate stress hormone secretion at least in part by an action in the hypothalamic paraventricular nucleus, where the peptide's receptors have been localized. In addition, orexin acts in the brain to increase sympathetic tone and, therefore, mean arterial pressure and heart rate. We provide evidence for the role of endogenously produced hypocretin/orexin in the physiological response to immobilization stress and identify the receptor subtype responsible for this action of the peptide. Antagonism of the orexin type 1 receptor (OX1R) in the brain prevented the ACTH-stimulating effect of centrally administered hypocretin/orexin. Furthermore, pretreatment of animals with the OX1R antagonist blocked the ACTH response to immobilization/restraint stress. The OX1R antagonist did not, however, block the pharmacological or physiological release of prolactin in these two models. Antagonism of the OX1R also blocked the central action of orexin to elevate mean arterial pressures and heart rates in conscious rats. These data suggest receptor subtype-selective responses to hypocretin/orexin and provide further evidence for the importance of endogenously produced peptide in the physiological control of stress hormone secretion.

autonomic function; hypothalamus; adrenocorticotropin; prolactin



Address for reprint requests and other correspondence: W. K. Samson, Pharmacological and Physiological Science, Saint Louis Univ. School of Medicine, 1402 South Grand Blvd., St. Louis, MO 63104 (e-mail: samsonwk{at}slu.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. Wenzel, N. Grabinski, C. A. Knopp, A. Dendorfer, M. Ramanjaneya, H. S. Randeva, M. Ehrhart-Bornstein, P. Dominiak, and O. Johren
Hypocretin/orexin increases the expression of steroidogenic enzymes in human adrenocortical NCI H295R cells
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2009; 297(5): R1601 - R1609.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. L. C. Yosten and W. K. Samson
Nesfatin-1 exerts cardiovascular actions in brain: possible interaction with the central melanocortin system
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2009; 297(2): R330 - R336.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. C. da Costa Goncalves, J. Tank, A. Diedrich, A. Hilzendeger, R. Plehm, M. Bader, F. C. Luft, J. Jordan, and V. Gross
Diabetic Hypertensive Leptin Receptor-Deficient db/db Mice Develop Cardioregulatory Autonomic Dysfunction
Hypertension, February 1, 2009; 53(2): 387 - 392.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. C. da Costa-Goncalves, J. Tank, R. Plehm, A. Diedrich, M. Todiras, M. Gollasch, A. Heuser, M. Wellner, M. Bader, J. Jordan, et al.
Role of the Multidomain Protein Spinophilin in Blood Pressure and Cardiac Function Regulation
Hypertension, October 1, 2008; 52(4): 702 - 707.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Rao, M. Lu, F. Ge, D. J. Marsh, S. Qian, A. H. Wang, M. R. Picciotto, and X.-B. Gao
Regulation of Synaptic Efficacy in Hypocretin/Orexin-Containing Neurons by Melanin Concentrating Hormone in the Lateral Hypothalamus
J. Neurosci., September 10, 2008; 28(37): 9101 - 9110.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.